NFKB1 and cancer: Most cancer cells have aberrantly active NF-κβ, which is thought to be responsible for apoptosis suppression, angiogenesis promotion, epithelial-mesenchymal transition/metastasis facilitation, cellular metabolic alteration, anti-tumor immune response suppression, and accelerated cell proliferation.